Latest Period
Q4 2025
Security Snapshot
Q/C TECHNOLOGIES, INC. - Common Stock, par value $0.001 per share (QCLS) Institutional Ownership
CUSIP: 62856X300
13F Institutional Holders and Ownership History from Q3 2025 to Q4 2025
Institutions Reporting
18
Shares (Excl. Options)
752,721
Price
$3.99
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Symbol
- QCLS on Nasdaq
- Shares outstanding
- 11,453,200
- Price per share
- $3.77
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 752,721
- Total reported value
- $3,003,189
- % of total 13F portfolios
- 0%
- Share change
- +734,701
- Value change
- +$2,929,686
- Number of holders
- 18
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- QCLS - Q/C TECHNOLOGIES, INC. - Common Stock, par value $0.001 per share is tracked under CUSIP 62856X300.
- 18 institutions reported positions in Q4 2025.
- 1 significant owner is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 11 to 18 between Q3 2025 and Q4 2025.
- Reported value moved from $69,803 to $3,003,189.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Official SEC Source
Backed by Form 13F
Ownership context comes from SEC Form 13F and, when available, Schedule 13D/13G filings.
See Original FilingInvestment Quick Answers
What is CUSIP 62856X300?
CUSIP 62856X300 identifies QCLS - Q/C TECHNOLOGIES, INC. - Common Stock, par value $0.001 per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Continue Investment Research
- Latest 13F filings for new institutional portfolio disclosures.
- Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
- Latest 10-Q/10-K reports to cross-check issuer fundamentals.
- Recent insider transactions for management buying/selling context.
- SEC investors directory and top value investors for manager-level discovery.
- All institutional ownership pages to compare adjacent CUSIP pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 62856X300:
Significant Owners of Q/C TECHNOLOGIES, INC. - Common Stock, par value $0.001 per share (QCLS) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| PharmaCyte Biotech, Inc. | 74% | $28,646,744 | 8,475,368 | PharmaCyte Biotech, Inc. | 14 Nov 2025 |
As of 31 Dec 2025, 18 institutional investors reported holding 752,721 shares of Q/C TECHNOLOGIES, INC. - Common Stock, par value $0.001 per share (QCLS). This represents 6.6% of the company’s total 11,453,200 outstanding shares.